Genetics of Pelizaeus-Merzbacher disease

M E Hodes1, V M Pratt, S R Dlouhy

  • 1Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis 46202-5251.

Insights

Pelizaeus-Merzbacher disease (PMD) is a dysmyelination disorder caused by reduced proteolipid protein (PLP) production. Genetic mutations in the PLP gene explain some PMD cases, revealing a spectrum of related X-linked conditions.

Area of Science:

  • Neuroscience
  • Genetics
  • Biochemistry

Background:

  • Pelizaeus-Merzbacher disease (PMD) is a recognized clinical entity characterized by dysmyelination.
  • This condition results from impaired myelin sheath formation due to reduced production of proteolipid protein (PLP).

Purpose of the Study:

  • To clarify the genetic basis and evolving nosology of Pelizaeus-Merzbacher disease.
  • To investigate the role of the proteolipid protein (PLP) gene in PMD and related disorders.

Main Methods:

  • Genetic analysis of the proteolipid protein (PLP) gene in patients diagnosed with PMD.
  • Linkage analysis to identify genetic associations in cases without coding region mutations in PLP.
  • Review of clinical presentations and genetic findings to refine disease classification.

Main Results:

  • Mutations in the coding region of the proteolipid protein (PLP) gene are identified in approximately 30% of PMD patients.
  • The PLP gene, located at Xq22, follows an X-linked inheritance pattern, with some mutations exhibiting expression in females.
  • Linkage between PMD and the PLP gene is observed even in patients lacking mutations in the PLP coding region.
  • The spectrum of PLP-associated disorders is expanding, encompassing conditions previously classified separately, including some forms of X-linked spastic paraplegia (SPG2).

Conclusions:

  • Pelizaeus-Merzbacher disease represents a spectrum of dysmyelinating disorders linked to the proteolipid protein (PLP) gene.
  • The understanding of PMD's genetic basis and classification is evolving, with implications for diagnosis and genetic counseling.
  • Some conditions clinically resembling PMD may have different genetic etiologies and may not be X-linked.

Related Concept Videos

Genetic Lingo01:11

Genetic Lingo

Overview
Pedigree Analysis01:35

Pedigree Analysis

Overview
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
Sex-linked Disorders01:43

Sex-linked Disorders

Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
Incomplete Dominance01:43

Incomplete Dominance

Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
Lethal Alleles02:41

Lethal Alleles

Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...